MedTrace Logo

Efficiency of a Small-peptide Enteral Feeding Formula Compared to a Whole-protein Formula

NCT01833624 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 206

Last updated 2016-08-05

No results posted yet for this study

Summary

An early and efficient enteral nutritional support could improve the clinical outcomes of brain injured critically ill patients. Gastrointestinal feeding intolerance defined as an increased gastric residual volume frequently occurs in these patients.

Previous experimental studies have suggested that a small-peptide enteral feeding formula could promote the gastric emptying compared to a whole-protein formula. An improved gastrointestinal tolerance of enteral nutrition should allow a rapid increase in the daily caloric intake and enhance nutritional support of brain injured critically ill patients.

Conditions

  • Traumatic and/or Non-traumatic Brain Injury
  • Critically Ill

Interventions

DIETARY_SUPPLEMENT

Peptamen® AF

Comparison of two types of enteral nutrition feeding: Peptamen® AF and Sondalis® HP

DIETARY_SUPPLEMENT

Sondalis® HP

Sponsors & Collaborators

  • Nestlé Foundation

    collaborator OTHER

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Principal Investigators

  • Gilles Blasco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2017-05-31
Completion
2017-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01833624 on ClinicalTrials.gov